XML 93 R67.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Aggregate Intrinsic Value          
Issuance of shares of common stock     $ 15,923 $ 12,508  
Stock-Based Compensation     Stock-Based Compensation 
The stock-based compensation expense under all equity plans and its classification in the unaudited consolidated statements of operations for the three and nine months ended March 31, 2022 and 2021 were as follows:
Three Months Ended
March 31,
Nine Months Ended
March 31,
 2022202120222021
 (Dollars in Thousands)
Recorded as expenses:    
Cost of maintenance$150 $234 $505 $688 
Cost of services and other225 412 731 1,198 
Selling and marketing1,687 1,869 5,324 4,655 
Research and development1,702 2,273 5,434 6,515 
General and administrative3,993 4,437 13,719 11,533 
Total stock-based compensation$7,757 $9,225 $25,713 $24,589 

A summary of stock option and restricted stock unit (“RSU”) activity under all equity plans for the nine months ended March 31, 2022 is as follows:
 Stock OptionsRestricted Stock Units
 SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
(Years)
Aggregate
Intrinsic Value
(in 000’s)
SharesWeighted
Average
Grant Date
Fair Value
Outstanding at June 30, 20211,285,221 $94.18 6.93$56,032 362,024 $128.66 
Granted274,777 130.29   393,769 135.79 
Settled (RSUs)—    (196,532)127.62 
Exercised (Stock options)(171,895)89.35   —  
Cancelled / Forfeited(37,721)128.78   (36,208)131.76 
Outstanding at March 31, 20221,350,382 $100.69 6.78$85,818 523,053 $134.52 
Vested and exercisable at March 31, 2022869,953 $84.81 5.72$70,087  
Vested and expected to vest as of March 31, 20221,262,415 $99.16 6.68$83,580 409,774 $134.27 
 
As of March 31, 2022, the RSUs expected to vest included 169,351 shares of RSUs granted during second and third quarter of fiscal 2022 which vest over a 12 to 18 month period contingent upon the close of the Transactions and continued service. Stock-based compensation expense associated with these awards will begin recognition at the closing date of the Transactions. Accordingly, there was no stock-based compensation expense recognized during the three and nine months ended March 31, 2022 for these awards.

The weighted average estimated fair value of option awards granted was $47.93 and $45.63 during the three months ended March 31, 2022 and 2021, respectively, and $40.50 and $38.76 during the nine months ended March 31, 2022 and 2021, respectively.
 
We utilized the Black-Scholes option valuation model with the following weighted average assumptions:
Nine Months Ended
March 31,
 20222021
Risk-free interest rate0.8 %0.4 %
Expected dividend yield0.0 %0.0 %
Expected life (in years)4.74.7
Expected volatility factor35.4 %34.1 %
As of March 31, 2022, the total future unrecognized compensation cost related to stock options and RSUs was $13.7 million and $46.0 million, respectively, and was expected to be recorded over a weighted average period of 2.57 years and 2.74 years, respectively. Of the $46.0 million total future unrecognized compensation cost related to RSUs, $24.2 million was associated with the awards that are contingent upon the close of the Transactions.

As of March 31, 2022, common stock reserved for future issuance under equity compensation plans was 4.9 million shares.
   
Stock Options          
Stock options activity          
Outstanding, beginning of period (in shares)     1,285,221    
Exercised (in shares)     (171,895)    
Cancelled / Forfeited (in shares)     (37,721)    
Outstanding, end of period (in shares) 1,350,382   1,350,382   1,285,221
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     274,777    
Vested and exercisable, end of period (in shares) 869,953   869,953    
Vested and expected to vest, end of period (in shares) 1,262,415   1,262,415    
Weighted Average Exercise Price          
Outstanding, beginning of period (in dollars per share)     $ 94.18    
Granted (in dollars per share)     130.29    
Exercised (in dollars per share)     89.35    
Cancelled / Forfeited (in dollars per share)     128.78    
Outstanding, end of period (in dollars per share) $ 100.69   100.69   $ 94.18
Vested and exercisable, end of period (in dollars per share) 84.81   84.81    
Vested and expected to vest, end of period (in dollars per share) $ 99.16   $ 99.16    
Weighted Average Remaining Contractual Term          
Outstanding, end of period     6 years 9 months 10 days   6 years 11 months 4 days
Vested and exercisable, end of period     5 years 8 months 19 days    
Vested and expected to vest, end of period     6 years 8 months 4 days    
Aggregate Intrinsic Value          
Outstanding, end of period $ 85,818   $ 85,818   $ 56,032
Vested and exercisable, end of period 70,087   70,087    
Vested and expected to vest, end of period 83,580   83,580    
Total unrecognized compensation cost $ 13,700   $ 13,700    
Total unrecognized compensation cost, period of recognition     2 years 6 months 25 days    
Weighted average fair value (in dollars per share) $ 47.93 $ 45.63 $ 40.50 $ 38.76  
Restricted Stock Units          
Aggregate Intrinsic Value          
Total unrecognized compensation cost $ 46,000   $ 46,000    
Total unrecognized compensation cost, period of recognition     2 years 8 months 26 days